companydata.dkNovo Nordisk North America Operations A/S: Financial statements 2019
CVR: 33761201
Novo Nordisk North America Operations A/S (CVR 33761201) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 189,945,000 compared with DKK 730,000 the year before. Equity amounted to DKK 728,462,000. The solvency ratio was 100%.
- Profit/Loss
- 189,945,000 kr.
- Equity
- 728,462,000 kr.
- Total Assets
- 728,760,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | 189.9 mio. | 728.5 mio. | - |
| 2018 | - | - | 730 t. | 3.4 mio. | - |
| 2017 | - | - | -2.4 mio. | 2.7 mio. | - |
| 2016 | - | - | -5.3 mio. | 25.1 mio. | - |
| 2015 | - | - | -5.7 mio. | 40.6 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
On November 29, 2019, the company changed its name from Novo Nordisk Invest 3 A/S to Novo Nordisk North America Operations A/S.
Novo Nordisk North America Operations A/S has published its annual report for 2018. The net result was DKK 730,000.
About Novo Nordisk North America Operations A/S
Novo Nordisk North America Operations A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2011. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named Novo Nordisk Invest 3 A/S and NOVO NORDISK REGION NORTH AMERICA II A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. In 2025, the company reported a gross profit of DKK -59,000 and a net result of DKK -74,142,000 compared with DKK -89,167,000 the year before. Equity amounted to DKK 60,045,000.